Cilfa Opposition, Firsocostat 2 (R) 2 (I (2 (2 Methoxyphenyl) 2 Tetrahydro 2 H Pyran 4 Yl)Oxy)Ethyl) 5 Methyl 6 (Oxazol2 Yl) 2,4 Dioxo 1,2 Dihydrothieno[2, 3 D]Pyrlmidin 3 (4 H) Yl) 2 Methylpropanoic Acid, (Ar107790 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, Desmopressin, (AR107948A2)
Countries: Argentina Date: 2018
-
CILFA opposition, eltrombopag, (AR107711A2)
Countries: Argentina Date: 2018
-
CILFA opposition, progesterone, (AR108074A1)
Countries: Argentina Date: 2018
-
CILFA opposition, vinorelbine, (AR107829A1)
Countries: Argentina Date: 2018
-
CILFA opposition, progesterone - estradiol, (AR108073A1)
Countries: Argentina Date: 2018
-
CILFA opposition, LSD1 inhibitor, (AR107871A1)
Countries: Argentina Date: 2018
-
CILFA opposition, mesalazine, (AR108231A1)
Countries: Argentina Date: 2018
-
CILFA opposition, progesterone, (AR108075A1)
Countries: Argentina Date: 2018
-
CILFA opposition, Progesterone, (AR108072A1)
Countries: Argentina Date: 2018
-
CILFA opposition, nicotamide, (AR108233A1)
Countries: Argentina Date: 2018